vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.
SMARTFINANCIAL INC. is the larger business by last-quarter revenue ($53.8M vs $31.1M, roughly 1.7× LIFECORE BIOMEDICAL, INC. \DE\). SMARTFINANCIAL INC. runs the higher net margin — 25.4% vs -32.1%, a 57.5% gap on every dollar of revenue. Over the past eight quarters, SMARTFINANCIAL INC.'s revenue compounded faster (15.4% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.
LFCR vs SMBK — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $53.8M |
| Net Profit | $-10.0M | $13.7M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | — |
| Net Margin | -32.1% | 25.4% |
| Revenue YoY | -4.5% | — |
| Net Profit YoY | -52.0% | 21.6% |
| EPS (diluted) | $-0.29 | $0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $53.8M | ||
| Q4 25 | — | $53.3M | ||
| Q3 25 | $31.1M | $51.1M | ||
| Q2 25 | — | $49.2M | ||
| Q1 25 | $35.2M | $46.8M | ||
| Q4 24 | $32.6M | $46.8M | ||
| Q3 24 | $24.7M | $44.2M | ||
| Q2 24 | — | $40.4M |
| Q1 26 | — | $13.7M | ||
| Q4 25 | — | $13.7M | ||
| Q3 25 | $-10.0M | $13.7M | ||
| Q2 25 | — | $11.7M | ||
| Q1 25 | $-14.8M | $11.3M | ||
| Q4 24 | $-6.6M | $9.6M | ||
| Q3 24 | $-16.2M | $9.1M | ||
| Q2 24 | — | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 31.3% | ||
| Q3 25 | -9.9% | 33.2% | ||
| Q2 25 | — | 29.0% | ||
| Q1 25 | -25.7% | 29.0% | ||
| Q4 24 | -6.0% | 26.5% | ||
| Q3 24 | -46.9% | 24.3% | ||
| Q2 24 | — | 25.6% |
| Q1 26 | — | 25.4% | ||
| Q4 25 | — | 25.7% | ||
| Q3 25 | -32.1% | 26.8% | ||
| Q2 25 | — | 23.8% | ||
| Q1 25 | -42.0% | 24.0% | ||
| Q4 24 | -20.2% | 20.6% | ||
| Q3 24 | -65.7% | 20.7% | ||
| Q2 24 | — | 19.8% |
| Q1 26 | — | $0.81 | ||
| Q4 25 | — | $0.81 | ||
| Q3 25 | $-0.29 | $0.81 | ||
| Q2 25 | — | $0.69 | ||
| Q1 25 | $-0.47 | $0.67 | ||
| Q4 24 | $-0.25 | $0.57 | ||
| Q3 24 | $-0.53 | $0.54 | ||
| Q2 24 | — | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $346.1M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $562.2M |
| Total Assets | $235.2M | $5.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $346.1M | ||
| Q4 25 | — | $464.4M | ||
| Q3 25 | $18.9M | $557.1M | ||
| Q2 25 | — | $365.1M | ||
| Q1 25 | $5.4M | $423.0M | ||
| Q4 24 | $9.5M | $387.6M | ||
| Q3 24 | — | $192.9M | ||
| Q2 24 | — | $342.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | $1.3M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | $124.9M | $7.6M | ||
| Q4 24 | $111.3M | $8.1M | ||
| Q3 24 | $106.3M | $9.0M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | — | $562.2M | ||
| Q4 25 | — | $552.4M | ||
| Q3 25 | $-10.5M | $538.4M | ||
| Q2 25 | — | $519.0M | ||
| Q1 25 | $2.2M | $505.8M | ||
| Q4 24 | $15.4M | $491.3M | ||
| Q3 24 | $-3.9M | $489.0M | ||
| Q2 24 | — | $472.5M |
| Q1 26 | — | $5.9B | ||
| Q4 25 | — | $5.9B | ||
| Q3 25 | $235.2M | $5.8B | ||
| Q2 25 | — | $5.5B | ||
| Q1 25 | $237.7M | $5.4B | ||
| Q4 24 | $255.4M | $5.3B | ||
| Q3 24 | $246.8M | $4.9B | ||
| Q2 24 | — | $4.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | 56.05× | 0.02× | ||
| Q4 24 | 7.20× | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | — |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $61.7M | ||
| Q3 25 | $1.8M | $16.9M | ||
| Q2 25 | — | $14.0M | ||
| Q1 25 | $1.2M | $14.3M | ||
| Q4 24 | $-6.1M | $52.7M | ||
| Q3 24 | $-613.0K | $12.4M | ||
| Q2 24 | — | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $59.3M | ||
| Q3 25 | $25.0K | $16.6M | ||
| Q2 25 | — | $13.2M | ||
| Q1 25 | $-4.3M | $13.4M | ||
| Q4 24 | $-8.6M | $46.3M | ||
| Q3 24 | $-4.0M | $11.3M | ||
| Q2 24 | — | $15.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 111.3% | ||
| Q3 25 | 0.1% | 32.4% | ||
| Q2 25 | — | 26.9% | ||
| Q1 25 | -12.1% | 28.5% | ||
| Q4 24 | -26.3% | 98.9% | ||
| Q3 24 | -16.3% | 25.7% | ||
| Q2 24 | — | 38.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.5% | ||
| Q3 25 | 5.6% | 0.6% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | 15.5% | 2.0% | ||
| Q4 24 | 7.5% | 13.7% | ||
| Q3 24 | 13.9% | 2.4% | ||
| Q2 24 | — | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.50× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.20× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | — | 5.47× | ||
| Q3 24 | — | 1.36× | ||
| Q2 24 | — | 2.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
SMBK
| Net Interest Income | $45.9M | 85% |
| Noninterest Income | $7.9M | 15% |
